Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2023
Postoperative Management of Recurrence After Radiosurgery and Surgical Resection for Brain Metastases and Predicting Benefit From Adjuvant Radiation, Samantha M Buszek, Benjamin Tran, James P Long, et al.
Precision Modulation of Dysbiotic Adult Microbiomes With a Human-Milk-Derived Synbiotic Reshapes Gut Microbial Composition and Metabolites, Julie E Button, Casey M Cosetta, Abigail L Reens, et al.
Outcomes Following Extracorporeal Membrane Oxygenation for Severe COVID-19 in Pregnancy or Post Partum, John J Byrne, Amir A Shamshirsaz, Alison G Cahill, et al.
Within Subject Cross-Tissue Analyzes of Epigenetic Clocks In Substance Use Disorder Postmortem Brain and Blood, Brenda Cabrera-Mendoza, Laura Stertz, Katherine Najera, et al.
AgRP Neurons Are Not Indispensable for Body Weight Maintenance in Adult Mice, Jing Cai, Jing Chen, Joshua Ortiz-Guzman, et al.
Head and Neck Radiation Therapy Patterns of Practice Variability Identified as a Challenge to Real-World Big Data: Results From the Learning from Analysis of Multicentre Big Data Aggregation (LAMBDA) Consortium, Amanda Caissie, Michelle Mierzwa, Clifton David Fuller, et al.
Monoallelic Variation In Dhx9, The Gene Encoding The Dexh-Box Helicase Dhx9, Underlies Neurodevelopment Disorders and Charcot-Marie-Tooth Disease, Daniel G Calame, Tianyu Guo, Chen Wang, et al.
Genome-Wide Analysis of the Interplay Between Chromatin-Associated RNA and 3D Genome Organization in Human Cells, Riccardo Calandrelli, Xingzhao Wen, John Lalith Charles Richard, et al.
Noncoding RNAs: Hope and Hype at 30 Years, George A Calin
A Scientific Communication Mentoring Intervention Benefits Diverse Mentees With Language Variety Related Discomfort, Carrie A Cameron, Hwa Young Lee, Cheryl B Anderson, et al.
Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer, D Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, et al.
Spatially-Aware Clustering Improves Ajcc-8 Risk Stratification Performance in Oropharyngeal Carcinomas, Guadalupe Canahuate, Andrew Wentzel, Abdallah S R Mohamed, et al.
Bayesian Approach for Design and Analysis of Medical Device Trials in the Era of Modern Clinical Studies, Han Cao, Chen Yao, and Ying Yuan
Intensity Modulated Proton Arc Therapy via Geometry-Based Energy Selection for Ependymoma, Wenhua Cao, Yupeng Li, Xiaodong Zhang, et al.
Plants As Vectors for Environmental Prion Transmission, Christina M Carlson, Samuel Thomas, Matthew W Keating, et al.
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101), Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
Cannabinoids in Periodontology: Where Are We Now?, Yésica Carmona Rendón, Hernán Santiago Garzón, Bruno Bueno-Silva, et al.
The Wnt/Pcp Formin Daam1 Drives Cell-Cell Adhesion During Nephron Development, Heather S Carr, Yan Zuo, and Jeffrey A Frost
Epichaperome Inhibition Targets TP53-Mutant AML and AML Stem/Progenitor Cells, Bing Z Carter, Po Yee Mak, Muharrem Muftuoglu, et al.
Combined Inhibition of Bcl-2 and Mcl-1 Overcomes Bax Deficiency-Mediated Resistance of TP53-Mutant Acute Myeloid Leukemia to Individual BH3 Mimetics, Bing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Correction: Combined Inhibition of Bcl-2 and Mcl-1 Overcomes Bax Deficiency-Mediated Resistance of TP53-Mutant Acute Myeloid Leukemia to Individual BH3 Mimetics, Bing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Inhibition of Menin, BCL-2, and FLT3 Combined With a Hypomethylating Agent Cures NPM1/FLT3-Itd/-Tkd Mutant Acute Myeloid Leukemia in a Patient-Derived Xenograft Model, Bing Z Carter, Po Yee Mak, Wenjing Tao, et al.
An Echogenic Clot Method For Thrombolysis Monitoring In Thrombotic Stroke Models, Dalton E Carter, Tao Peng, Melanie R Moody, et al.
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial, Tina Cascone, Gozde Kar, Jonathan D Spicer, et al.
Neoadjuvant Chemotherapy Plus Nivolumab With or Without Ipilimumab in Operable Non-small Cell Lung Cancer: The Phase 2 Platform NEOSTAR Trial, Tina Cascone, Cheuk H Leung, Annikka Weissferdt, et al.